When was Until Labs founded?

Until Labs was founded in 2021 and raised its 1st funding round 4 years after it was founded.

Where is Until Labs located?

Until Labs is headquartered in San Francisco, United States.

Who is the current CEO of Until Labs?

Laura Deming of Until Labs. They have also founded 2 companies.

How many employees does Until Labs have?

As of Jul 31, 2026, the latest employee count at Until Labs is 57.

Is Until Labs a funded company?

Until Labs is a funded company, having raised a total of $***** in its 1st and only funding round, a Series A round on Sep 22, 2025.

When was the latest funding round of Until Labs?

Until Labs' latest funding was a $***** Series A round on Sep 22, 2025, with participation from 3 investors. Its primary sector is Transplant Medicine. In United States, the Transplant Medicine sector has seen $160M in funding in 2026 to date.

Where does Until Labs rank among its competitors?

Until Labs ranks 6th amongst 32 active competitors, of which 10 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was Bridge to Life, which secured $110M in Aug, 2026.

Who are the top competitors of Until Labs?

Until Labs' top competitors include OrganOx, TransMedics and Bridge to Life. Among them, Bridge to Life secured the most recent funding round in August, 2026.

Until Labs - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of reversible cryopreservation systems for human organs and tissues. The company translates cryobiology fundamentals into engineered workflows for organ preservation. It focuses on perfusion, cryoprotectants, cooling, rewarming, and organ health assessment. The aim is to address the donor organ procurement and matching challenges.

Website: www.untillabs.com/
Social
Email ID: *****@untillabs.com

Key Metrics

Founded Year

2021

Location

San Francisco, United States

Stage

Series A

Total Funding

$100M in 1 round

Latest Funding Round

Series A, Sep 22, 2025, $*****

Investors

Founders Fund & 2 more

Ranked

6^th among 32 active competitors

Employee Count

57 as on Jul 31, 2026

Similar Companies

OrganOx & 38 more

View Until Labs' full profile

Until Labs has raised a total funding of $100M over 1 round. Its latest funding round was a Series A round on Sep 22, 2025 for $*****. 3 investors participated in its latest round. Until Labs has 3 institutional investors.

Here is the list of recent funding rounds of Until Labs:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 22, 2025	1920166	Series A	9240621	9571044	3774983	3281033

Access funding benchmarks and valuations. Sign up today!

View details of Until Labs's funding rounds and investors

The founders of Until Labs are Laura Deming, Hunter Davis, Hunter Davis and Laura Deming. Laura Deming is the CEO of Until Labs.

Here are the details of Until Labs' key team members:

Laura Deming: Co-Founder & CEO of Until Labs and founder of 1 other company.
Contact Info: 1 email address
Hunter Davis: Co-Founder & CSO of Until Labs.
Contact Info: 2 email addresses
Hunter Davis: Founder of Until Labs.
Contact Info: 1 email address
Laura Deming: Founder of Until Labs.
Contact Info: 1 email address

View details of Until Labs's Founder profiles and Board Members

Until Labs' employee count trend

Until Labs has 57 employees as of Jul 26. Here is Until Labs's employee count trend over the years:

Uncover Until Labs' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Until Labs include OrganOx, TransMedics and Bridge to Life. Here is the list of Top 10 competitors of Until Labs, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	OrganOx 2008, Oxford (United Kingdom), Acquired	Provider of a storage and transport system for harvested organs	$45.4M	Health Quest Capital, BGF & 61 others	75/100
2nd	TransMedics 1998, Andover (United States), Public	Developer of organ transplantation technology	$266M	Kleiner Perkins, Foundation Capital & 19 others	67/100
3rd	Bridge to Life 2012, Duluth (United States), Series C	Provider of cold storage solutions for the preservation of organ transplants	$167M	Perceptive Advisors, Soleus Capital & 2 others	58/100
4th	Paragonix Technologies 2010, Boston (United States), Acquired	Organ preservation technology improving transplant outcomes with digital tracking and clinical support	$25.1M	Signet Healthcare Partners, Massachusetts Life Sciences Center ... & 1 others	57/100
5th	Vascular Perfusion 2016, San Antonio (United States), Series D	Developer of a device for organ preservation	$152M	Capital Factory, Military Health	53/100
6th	Until Labs 2021, San Francisco (United States), Series A	Developer of reversible cryopreservation systems for human organs and tissues	$100M	Founders Fund, Lux Capital & 1 others	45/100
7th	XVIVO 1998, Gothenburg (Sweden), Public	Provider of organ preservation technologies and services. It offers machine perfusion technologies for kidneys, livers, and lungs, and a solution for cold static storage of lungs. The company also provides organ recovery and perfusion services. These technologies aim to increase organ utilization, extend preservation time, enable organ assessment, and improve transplant outcomes. A platform for sharing knowledge and experiences related to organ perfusion is also offered.	-	Europa	45/100
8th	ADVITOS 2005, Munich (Germany), Series B	Provider of multi-organ support systems	$23.8M	Credit Mutuel Equity, EIC Fund & 13 others	43/100
9th	Organ Recovery Systems 1998, Itasca (United States), Funding Raised	Organ preservation products and services improving transplant outcomes for patients	-	HHS	38/100
10th	ScubaTx 2020, Newcastle Upon Tyne (United Kingdom), Seed	Developer of organ preservation technology for transport and medical transplantation	$3.71M	Praetura Ventures, Conduit Connect & 2 others	36/100